Federal Circuit Upholds Ruling Invalidating University of Rochester's Patent

Law360, New York (February 14, 2004, 12:00 AM EST) -- The U.S. Court of Appeals for the Federal Circuit has upheld a lower court’s dismissal of the University of Rochester’s lawsuit against Pfizer over the patent for the best-selling arthritis drug Celebrex.

The court let stand a ruling by U.S. District Judge David G. Larimer in Rochester that found in March 2003 that the University of Rochester patent for so-called cox-2 inhibitors is invalid.

Larimer had declared the patent invalid because the university’s scientists did not produce a compound or pill. He described the university’s patent...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.